Literature DB >> 8256552

Increased generation of superoxide radicals in the blood of MS patients.

A Glabiński1, N S Tawsek, G Bartosz.   

Abstract

Increased generation of superoxide radical (O2-) in the blood stimulated with phorbol myristate acetate (PMA) has been found in multiple sclerosis (MS) patients. All the subjects studied were non-smokers and received the same hospital diet. In the MS group treated with prednisone superoxide radical generation was lower than in untreated patients, but was still above the level of O2- generation in controls. Plasma lipid peroxidation products, measured as thiobarbituric-reactive substances, were slightly elevated in both prednisone treated and non-treated MS patients in comparison with controls. Erythrocyte superoxide dismutase activity (SOD) was at the same level in MS and control groups. These results suggest that increased generation of reactive oxygen species may occur in MS patients during acute relapse. This phenomenon may be involved in the pathomechanism of demyelinating disorders.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256552     DOI: 10.1111/j.1600-0404.1993.tb04212.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

1.  Cerebrospinal fluid and plasma oxidative stress biomarkers in different clinical phenotypes of neuroinflammatory acute attacks. Conceptual accession: from fundamental to clinic.

Authors:  Srdjan Ljubisavljevic; Ivana Stojanovic; Slobodan Vojinovic; Dragan Stojanov; Svetlana Stojanovic; Gordana Kocic; Dejan Savic; Tatjana Cvetkovic; Dusica Pavlovic
Journal:  Cell Mol Neurobiol       Date:  2013-05-16       Impact factor: 5.046

2.  Influence of the use of statin on the stability of erythrocyte membranes in multiple sclerosis.

Authors:  Mariana Vaini de Freitas; Marcela Ramos de Oliveira; Diogo Fernandes dos Santos; Rita de Cássia Mascarenhas Netto; Sheila Bernardino Fenelon; Nilson Penha-Silva
Journal:  J Membr Biol       Date:  2010-02-10       Impact factor: 1.843

3.  Rg3-enriched Korean Red Ginseng extract inhibits blood-brain barrier disruption in an animal model of multiple sclerosis by modulating expression of NADPH oxidase 2 and 4.

Authors:  Min Jung Lee; Jong Hee Choi; Jinhee Oh; Young Hyun Lee; Jun-Gyo In; Byung-Joon Chang; Seung-Yeol Nah; Ik-Hyun Cho
Journal:  J Ginseng Res       Date:  2020-09-11       Impact factor: 6.060

4.  Inhibition of NADPH oxidase activation reduces EAE-induced white matter damage in mice.

Authors:  Bo Young Choi; Jin Hee Kim; A Ra Kho; In Yeol Kim; Song Hee Lee; Bo Eun Lee; Eunhi Choi; Min Sohn; Mackenzie Stevenson; Tae Nyoung Chung; Tiina M Kauppinen; Sang Won Suh
Journal:  J Neuroinflammation       Date:  2015-05-28       Impact factor: 8.322

Review 5.  N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.

Authors:  Reza Bavarsad Shahripour; Mark R Harrigan; Andrei V Alexandrov
Journal:  Brain Behav       Date:  2014-01-13       Impact factor: 2.708

6.  A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis.

Authors:  David Wheeler; Veera Venkata Ratnam Bandaru; Peter A Calabresi; Avindra Nath; Norman J Haughey
Journal:  Brain       Date:  2008-09-04       Impact factor: 13.501

Review 7.  Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.

Authors:  Gu-Jiun Lin; Shing-Hwa Huang; Shyi-Jou Chen; Chih-Hung Wang; Deh-Ming Chang; Huey-Kang Sytwu
Journal:  Int J Mol Sci       Date:  2013-05-31       Impact factor: 5.923

8.  Neuroprotective effect of nitric oxide donor isosorbide-dinitrate against oxidative stress induced by ethidium bromide in rat brain.

Authors:  Omar M E Abdel-Salam; Yasser Ashry Khadrawy; Nadia A Mohammed
Journal:  EXCLI J       Date:  2012-03-29       Impact factor: 4.068

Review 9.  Demyelination: the role of reactive oxygen and nitrogen species.

Authors:  K J Smith; R Kapoor; P A Felts
Journal:  Brain Pathol       Date:  1999-01       Impact factor: 6.508

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.